These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29371234)

  • 21. The effect of a low-glycemic diet vs a standard diet on blood glucose levels and macronutrient intake in children with type 1 diabetes.
    Rovner AJ; Nansel TR; Gellar L
    J Am Diet Assoc; 2009 Feb; 109(2):303-7. PubMed ID: 19167958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
    Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disordered eating behaviors in youth with type 1 diabetes: prospective pilot assessment following initiation of insulin pump therapy.
    Markowitz JT; Alleyn CA; Phillips R; Muir A; Young-Hyman D; Laffel LM
    Diabetes Technol Ther; 2013 May; 15(5):428-33. PubMed ID: 23550556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
    Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
    Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disordered eating behaviors are associated with poorer diet quality in adolescents with type 1 diabetes.
    Tse J; Nansel TR; Haynie DL; Mehta SN; Laffel LM
    J Acad Nutr Diet; 2012 Nov; 112(11):1810-4. PubMed ID: 23102180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.
    Buse JB; Kudva YC; Battelino T; Davis SN; Shin J; Welsh JB
    Diabetes Technol Ther; 2012 Jul; 14(7):644-7. PubMed ID: 22524549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.
    Kahkoska AR; Adair LA; Aiello AE; Burger KS; Buse JB; Crandell J; Maahs DM; Nguyen CT; Kosorok MR; Mayer-Davis EJ
    Pediatr Diabetes; 2019 Aug; 20(5):556-566. PubMed ID: 30972889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Financial Incentives on Glucose Monitoring Adherence and Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Wong CA; Miller VA; Murphy K; Small D; Ford CA; Willi SM; Feingold J; Morris A; Ha YP; Zhu J; Wang W; Patel MS
    JAMA Pediatr; 2017 Dec; 171(12):1176-1183. PubMed ID: 29059263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased glycemic variability and decrease of the postprandial glucose contribution to HbA1c in obese subjects across the glycemic continuum from normal glycemia to first time diagnosed diabetes.
    Fysekidis M; Cosson E; Banu I; Duteil R; Cyrille C; Valensi P
    Metabolism; 2014 Dec; 63(12):1553-61. PubMed ID: 25308444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Glycemic Control in Nursing Home Residents with Diabetes.
    Retornaz F; Grino M; Mari L; Oliver C
    J Nutr Health Aging; 2017; 21(4):457-463. PubMed ID: 28346573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus.
    Peña NV; Torres M; Cardona JA; Iniesta R
    Diabetes Technol Ther; 2013 Feb; 15(2):136-42. PubMed ID: 23289433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shared Responsibility for Type 1 Diabetes Care Is Associated With Glycemic Variability and Risk of Glycemic Excursions in Youth.
    Marker AM; Noser AE; Clements MA; Patton SR
    J Pediatr Psychol; 2018 Jan; 43(1):61-71. PubMed ID: 28541572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.